🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Context. Essential tremor (ET) is a common disease, disabling in severe for...
Status
Unknown
Location
Hôpital Pitié Salpétrière
Start Date
2020-01-07
Trial ID
NCT04074031
Treatments Being Tested
The purpose of this clinical trial is to investigate Low Intensity Focused ...
Status
Recruiting
Location
Tampa General Hospital
Start Date
2019-11-27
Trial ID
NCT04197921
Treatments Being Tested
The purpose of this study is to assess the safety and feasibility of unilat...
Status
Active Not Recruiting
Location
University of North Carolina-Chapel Hill
Start Date
2018-04-24
Trial ID
NCT03417297
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of the ExA...
Status
Completed
Location
Division of Neurosurgery, Sunnybrook Health Sciences Centre
Start Date
2018-12-06
Trial ID
NCT03739905
Treatments Being Tested
This study is for people (children and adults) with a rare and aggressive b...
Status
Not Yet Recruiting
Location
Princess Maxima Center for pediatric oncology
Start Date
2026-05
Trial ID
NCT07562971
Treatments Being Tested
Parkinson's disease (PD) is a common, progressive, incurable neurodegenerat...
Status
Completed
Location
Hospital Universitario HM Puerta del Sur
Start Date
2020-11-25
Trial ID
NCT04692116
Treatments Being Tested
The purpose of this study is to evaluate the feasibility, safety, and effec...
Status
Active Not Recruiting
Location
The Ohio State University
Start Date
2024-06-04
Trial ID
NCT05032105
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of targete...
Status
Recruiting
Location
St. Joseph's Hospital and Medical Center
Start Date
2022-08-12
Trial ID
NCT05317858
The purpose of this study is to evaluate the safety and efficacy of targete...
Status
Completed
Location
University of California, Los Angeles
Start Date
2022-08-08
Trial ID
NCT05383872
Treatments Being Tested